Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of December 28th, 2020 – January 3rd, 2021.
Without further ado, let’s get started.
* Yahoo Finance readers, please click here to view the full article.
Following Horizons’ Quarterly Rebalance, Here’s What the Top 10 Holdings of Their HMMJ and HMUS Cannabis ETFs Look Like Now
On December 29, 2020, Horizons ETFs Management (Canada) announced it completed a quarterly rebalance of the holdings of its two Cannabis ETFs: Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ) and the Horizons U.S. Marijuana Index ETF (NEO: HMUS).
Psychedelics Are Winning Big With Major Players Drawing Serious Investment Interest
Money tends to follow efficacy in biotech and pharmaceutical investing, and psychedelics have certainly exhibited incredible efficacy. Indeed, 2020 has witnessed several Psychedelics IPO, crazy stock surges and some major financings. MindMed (OTCQB: MMEDF) recently closed an upsized $80 million bought deal and Silicon Valley billionaire Peter Thiel-backed psychedelic pioneers, Compass Pathways (NASDAQ: CMPS), were the first psychedelic company to debut on the NASDAQ this year.
It is Estimated the Combined Entity Will Be Valued at Roughly $3.9 Billion, Boasting Pro-Forma Yearly Sales of $685 Million
Earlier this month, cannabis growers Aphria (NYSE: APHA) and Tilray (NASDAQ: TLRY) announced a merger to create the largest enterprise in the industry by revenue. Aphria recently acquired SweetWater Brewing Company for $300 million. Tilray, meanwhile, has a joint venture with Anheuser-Busch InBev (NYSE: …